Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Accessible disulfide bonds and free thiol groups (sulfhydryls) are critical chemical moieties found on the surface of proteins and other biomolecules that participate in redox signaling and structural maintenance (Source: NIH, 2021). These groups are highly reactive and serve as "redox switches" that can alter the conformation and activity of enzymes, receptors, and transcription factors in response to the cellular environment (Source: MetwareBio, 2023). In many diseases, such as cancer and neurodegeneration, the balance of these groups is disrupted, leading to oxidative stress or aberrant signaling (Source: NIH, 2016). While not a single protein target, they are exploited in pharmacology through the use of thiol-modifying agents or as conjugation sites for targeted therapies like antibody-drug conjugates (Source: ACS, 2025). Targeting these groups allows for the modulation of broad biological processes, though it poses challenges regarding specificity and off-target effects. Furthermore, the accessibility of these bonds is a major determinant of their reactivity, often influenced by protein dynamics and the local microenvironment (Source: NIH, 2017).
Drugs interact with these groups via thiol-disulfide exchange, covalent modification (alkylation or arylation), or redox modulation to alter protein function or cellular redox state (Source: NIH, 2017; PNAS, 2004).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Accessible disulfide bonds and free thiol groups.